2-55867066-GA-G
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001039348.3(EFEMP1):c.*6del variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0261 in 1,612,118 control chromosomes in the GnomAD database, including 958 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.020 ( 54 hom., cov: 32)
Exomes 𝑓: 0.027 ( 904 hom. )
Consequence
EFEMP1
NM_001039348.3 3_prime_UTR
NM_001039348.3 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.340
Genes affected
EFEMP1 (HGNC:3218): (EGF containing fibulin extracellular matrix protein 1) This gene encodes a member of the fibulin family of extracellular matrix glycoproteins. Like all members of this family, the encoded protein contains tandemly repeated epidermal growth factor-like repeats followed by a C-terminus fibulin-type domain. This gene is upregulated in malignant gliomas and may play a role in the aggressive nature of these tumors. Mutations in this gene are associated with Doyne honeycomb retinal dystrophy. Alternatively spliced transcript variants that encode the same protein have been described.[provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 2-55867066-GA-G is Benign according to our data. Variant chr2-55867066-GA-G is described in ClinVar as [Likely_benign]. Clinvar id is 191301.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-55867066-GA-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.075 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EFEMP1 | NM_001039348.3 | c.*6del | 3_prime_UTR_variant | 12/12 | ENST00000355426.8 | ||
LOC112268416 | XR_002959388.2 | n.229-6813del | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EFEMP1 | ENST00000355426.8 | c.*6del | 3_prime_UTR_variant | 12/12 | 1 | NM_001039348.3 | P1 | ||
EFEMP1 | ENST00000394555.6 | c.*6del | 3_prime_UTR_variant | 11/11 | 1 | P1 | |||
EFEMP1 | ENST00000634374.1 | c.*6del | 3_prime_UTR_variant | 6/6 | 5 | ||||
EFEMP1 | ENST00000635671.1 | c.*1140del | 3_prime_UTR_variant, NMD_transcript_variant | 9/9 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0196 AC: 2973AN: 152026Hom.: 55 Cov.: 32
GnomAD3 genomes
AF:
AC:
2973
AN:
152026
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0290 AC: 7277AN: 251226Hom.: 233 AF XY: 0.0332 AC XY: 4507AN XY: 135756
GnomAD3 exomes
AF:
AC:
7277
AN:
251226
Hom.:
AF XY:
AC XY:
4507
AN XY:
135756
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0268 AC: 39169AN: 1459974Hom.: 904 Cov.: 30 AF XY: 0.0291 AC XY: 21106AN XY: 726300
GnomAD4 exome
AF:
AC:
39169
AN:
1459974
Hom.:
Cov.:
30
AF XY:
AC XY:
21106
AN XY:
726300
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0195 AC: 2972AN: 152144Hom.: 54 Cov.: 32 AF XY: 0.0205 AC XY: 1524AN XY: 74400
GnomAD4 genome
AF:
AC:
2972
AN:
152144
Hom.:
Cov.:
32
AF XY:
AC XY:
1524
AN XY:
74400
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
124
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | research | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Sep 28, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 03, 2014 | - - |
Doyne honeycomb retinal dystrophy Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 11, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at